PRA Group Reports Third Quarter 2026 Results

PRA Group reported Q3 2026 net income attributable to the company of $14.9 million, or $0.39 per diluted share, versus a $407.7 million loss in Q3 2025, which included a $412.6 million goodwill impairment. Portfolio income rose 5% to $270.8 million and adjusted cash efficiency improved by more than 200 basis points to 63%, while total cash collections declined to $535.6 million from $542.2 million and total portfolio revenue fell 8% to $285.1 million. Adjusted EBITDA for the 12 months ended September 30 increased 9% to $1.4 billion; after quarter-end, PRA issued $400 million of senior notes due 2033.

Analysis

Underlying cash generation is less compelling than the strategy narrative: collections declined modestly year over year, while portfolio revenue fell because unusually large recovery-estimate gains in the prior-year comparison did not repeat. The 200bp improvement in adjusted cash efficiency supports the cost-out thesis, but it does not yet establish durable top-line growth. The more consequential signal is capital deployment: US Core purchases fell sharply year over year, potentially preserving returns if auction pricing is unattractive, but also limiting the next vintage of collections. Europe is carrying more of the growth burden; monitor whether recent Europe ERC uplift converts into realized cash rather than further forecast revisions. The $400m notes extend maturities, but with borrowings already substantial and interest expense material, refinancing access is not the same as cheaper funding.

Near term, the conference call is the catalyst for purchase-yield discipline, funding cost and collection guidance. Over 1–3 months, watch cash collections against ERC and purchases against forward-flow deliveries. Over 6–18 months, technology/legal investment can create operating leverage, but execution and regulatory constraints on collection practices are key risks. Contrarian: the improvement may be real on costs but is not yet a clean earnings inflection; reported quarterly EPS and adjusted EBITDA can distract from softer collections and lower portfolio revenue. No reliable valuation or consensus data are supplied, so avoid assuming the results are mispriced.

Key Decisions for Investors

• Do not chase PRAA into the results; wait for the call and subsequent price discovery. Consider a measured long only if management confirms stable collection curves and attractive returns on new purchases, with position risk capped pending evidence that cash collections stabilize.
• Track quarterly US Core and Europe Core purchases, realized collections versus ERC, and cash efficiency. A sustained decline in collections or downward ERC revisions would falsify the improving-fundamentals thesis; stronger realized collections alongside disciplined purchase growth would support adding.
• Treat the new notes as a maturity-management positive, not a de-leveraging catalyst. Verify coupon, covenant headroom and refinancing terms in filings; deterioration in credit availability or rising funding costs would be a reason to reduce exposure.